mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.05 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.05 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.05 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.05 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.05 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.05 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.05 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.05 |